P
US7722880B2ExpiredUtilityPatentIndex 49

Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof

Assignee: RES DEV FOUNDATIONPriority: Feb 25, 2004Filed: Feb 25, 2005Granted: May 25, 2010
Est. expiryFeb 25, 2024(expired)· nominal 20-yr term from priority
Inventors:MCBRIDE JERE WWALKER DAVID HDOYLE CHRISTOPHER KUYLER
A61K 39/00A61K 38/00C07K 14/29A61K 2039/505Y02A50/30
49
PatentIndex Score
0
Cited by
36
References
6
Claims

Abstract

The present invention is directed to the cloning, sequencing, expression, and characterization of an immunoreactive ferric binding protein (Fbp) (38-kDa) protein of Ehrlichia canis encoded by a polynucleotide therefor. In particular embodiments, the protein is employed in an immunogenic composition, such as a vaccine. Methods to induce an immune reaction in an individual with compositions of the invention are provided.

Claims

exact text as granted — not AI-modified
1. An isolated polynucleotide, comprising:
 a) SEQ ID NO:2; or 
 b) a polynucleotide that is at least about 95% identical to SEQ ID NO:2. 
 
     
     
       2. The polypeptide of  claim 1 , comprised in a pharmaceutically acceptable excipient. 
     
     
       3. The polypeptide of  claim 1 , comprised in a pharmaceutical composition suitable as an immunogenic composition. 
     
     
       4. A method of inducing an immune response in an individual, comprising the step of administering to the individual a therapeutically effective amount of the polypeptide of  claim 1 , wherein said administering induces the immune response. 
     
     
       5. The polypeptide of  claim 1 , wherein the polypeptide of b) is a polypeptide that is at least 97% identical to SEQ ID NO:2. 
     
     
       6. The polypeptide of  claim 1 , wherein the polypeptide of b) is a polypeptide that is at least 99% identical to SEQ ID NO:2.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.